Severe asthma: from phenotypes to exacerbations

Thematic Poster
Chairs: S. Loukides (Athens, Greece), C. Gotera Rivera (Madrid, Spain)

Multi-ancestral meta-analysis yields novel genetic loci for asthma exacerbations E. Herrera Luis (La Laguna, Spain), V. Ortega (Scottsdale, United States), E. Ampleford (Winston-Salem, United States), Y. Sio (Singapore, Singapore), R. Granell (Oakfield Grove, United Kingdom), E. De Roos (Rotterdam, Netherlands), N. Terzikhan (Rottedam, Netherlands), E. Elorduy Vergara (Munich, Germany), N. Hernandez-Pacheco (Stockholm, Sweden), J. Perez-Garcia (La Laguna, Spain), E. Martin-Gonzalez (La Laguna, Spain), F. Lorenzo-Diaz (La Laguna, Spain), S. Hashimoto (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), A. Jorgensen (Liverpool, United Kingdom), Q. Yan (New York, United States), E. Forno (Pittsburgh, United States), S. Vijverberg (Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands), R. Lethem (Oakfield Grove, United Kingdom), A. Espuela-Ortiz (La Laguna, Spain), M. Gorenjak (Maribor, Slovenia), C. Eng (San Francisco, United States), R. González-Pérez (Santa Cruz de Tenerife, Spain), J. Hernández-Pérez (Santa Cruz de Tenerife, Spain), P. Poza-Guedes (Santa Cruz de Tenerife, Spain), O. Sardón (San Sebastián, Spain), P. Corcuera (San Sebastián, Spain), G. Hawkins (Winston-Salem, United States), A. Marsico (Munich, Germany), T. Bahmer (Kiel, Germany), K. Rabe (Kiel, Germany), G. Hansen (Hannover, Germany), M. Kopp (Lübeck, Germany), R. Rios (Salvador, Brazil), M. Cruz (Madrid, Spain), F. González-Barcala (Santiago de Compostela, Spain), J. Olaguibel (Madrid, Spain), V. Plaza (Madrid, Spain), S. Quirce (Madrid, Spain), G. Canino (San Juan, Puerto Rico), M. Cloutier (Farmington, United States), V. Del Pozo (Madrid, Spain), J. Rodriguez-Santana (San Juan, Puerto Rico), J. Korta-Murua (San Sebastián, Spain), J. Villar (Madrid, Spain), U. Potocnik (Maribor, Slovenia), C. Figueiredo (Salvador, Brazil), M. Kabesch (Regensburg, Germany), S. Mukhopadhyay (Brighton, United Kingdom), M. Pirmohamed (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom), E. Melén (Stockholm, Sweden), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Von Mutius (Munich, Germany), J. Celedón (Pittsburgh, United States), G. Brusselle (Rotterdam, Netherlands), F. Chew (Singapore, Singapore), E. Bleecker (Tucson, United States), D. Meyers (Tucson, United States), E. G Burchard (San Francisco, United States), M. Pino-Yanes (La Laguna, Spain)
Respiratory system modeling of impedance on the effect of simulated obstructive apnea in participants with and without asthma X. Cao (Toronto, Canada), N. Montazeri Ghahjaverestan (Toronto, Canada), B. Taghibeyglou (Toronto, Canada), J. H. T. Bates (Burlington, United States), A. Yadollahi (Toronto, Canada)
Respiratory muscle strength investigation in severe asthma patients with lung hyperinflation D. Butov (Kharkiv, Ukraine), Y. Feshchenko (Kyiv, Ukraine), G. Gumeniuk (Kyiv, Ukraine), S. Opimakh (Kyiv, Ukraine), M. Polianska (Kyiv, Ukraine), V. Ignatieva (Kyiv, Ukraine), S. Moskalenko (Kyiv, Ukraine), I. Zvol (Kyiv, Ukraine)
Perimenstrual worsening of asthma; prevalence and clinical outcomes in severe asthma population A. Mansur (Birmingham, United Kingdom), A. Bahron (Birmingham, United Kingdom), C. Reilly (Birmingham, United Kingdom), L. White (Birmingham, United Kingdom), J. Sullivan (Birmingham, United Kingdom)
Sputum eosinophilia is a useful biomarker for treatment failure of biologics for severe eosinophilic asthma T. Smidt-Hansen (Aarhus, Denmark), H. Andersen (Aarhus, Denmark), L. Pedersen (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), T. Skjold (Aarhus, Denmark), R. Poulsen (Aarhus, Denmark), S. Petersen (Aarhus, Denmark), H. Hoffmann (Aarhus, Denmark), J. Schmid (Aarhus, Denmark)
Optimizing adrenal insufficiency screening in severe asthma patients on biologic therapy I. Berrar Torre (London, United Kingdom), K. Simpson (London, United Kingdom), V. Greener (London, United Kingdom), B. Cushen (Dublin, Ireland), P. Patel (London, United Kingdom)
Discrepancies between anti-Intereukin5 (anti-IL5) starters from SHARP central registry and eligible patients in clinical trials S. Principe (1) Amsterdam (The Netherlands) 2) Palermo, Netherlands), L. Richards (Amsterdam (The Netherlands), Netherlands), S. Hashimoto (Amsterdam (The Netherlands), Netherlands), J. Kroes (Leeuwarden, Netherlands), J. Van Bragt (Amsterdam (The Netherlands), Netherlands), S. Vijverberg (Amsterdam (The Netherlands), Netherlands), J. Sont (Leiden, Netherlands), N. Scichilone (Palermo, Netherlands), K. Bieksiene (Kaunas, Lithuania), A. Brinke (Leeuwarden, Netherlands), Z. Csoma (Budapest, Hungary), B. Dahlén (Stockholm, Sweden), B. Gemicioglu (Istanbul, Turkey), I. Grisle (Riga, Latvia), P. Kuna (Lódz, Poland), Z. Lazic (Kragujevac, Republic of Serbia), F. Mihaltan (Bucarest, Romania), S. Popovic-Grle (Zagreb , Croatia), S. Skgrat (Ljubljana, Slovenia), A. Maitland Van Der Zee (Amsterdam (The Netherlands), Netherlands)
Identification of plasma fibrinogen-high asthma phenotype L. Valsecchi (Orbassano, Italy), A. Sprio (Orbassano, Italy), A. Baroso (Orbassano, Italy), M. Sciolla (Orbassano, Italy), V. Carriero (Orbassano, Italy), F. Bertolini (Orbassano, Italy), A. Di Stefano (Veruno, Italy), F. Ricciardolo (Orbassano, Italy)
REAL LIFE FOLLOW-UP OF PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH RESLIZUMAB. K. Liendo Martinez (Madrid, Spain), C. Correa Gutierrez (Madrid, Spain), F. De Castro Martínez (Madrid, Spain), J. Zichen (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. Garcia De Pedro (Madrid, Spain)
Hand grip strength as a screening tool for frailty in elderly patients with moderate to severe asthma R. Figueiredo (Feira De Santana (BA), Brazil), G. Pinheiro (Salvador, Brazil), V. Arata (Feira De Santana (BA), Brazil), M. Leal (Feira De Santana (BA), Brazil), C. Santana (Salvador, Brazil), J. Contreras (Feira De Santana (BA), Brazil), J. De Bessa Junior (Feira De Santana (BA), Brazil), A. Cruz (Salvador, Brazil)
Body Mass Composition in asthmatics according to inflammatory phenotypes (SAMBA trial)> S. Ziant (LIEGE, Belgium), S. Louis (LIEGE, Belgium), S. Graff (LIEGE, Belgium), C. Moermans (LIEGE, Belgium), M. Henket (LIEGE, Belgium), R. Deroisy (LIEGE, Belgium), R. Louis (LIEGE, Belgium), J. Kaux (LIEGE, Belgium), T. Bury (LIEGE, Belgium), F. Schleich (LIEGE, Belgium)
Effects of biologics on systemic and airway inflammation in severe asthma: a real-life study F. Ardesi (Varese-Como, Italy), D. Visca (Tradate, Italy), P. Pignatti (Pavia, Italy), M. Zappa (Varese-Como, Italy), R. Centis (Tradate, Italy), F. Oliva (Tradate, Italy), F. Rusconi (Varese-Como, Italy), O. Mentasti (Tradate, Italy), G. Migliori (Tradate, Italy), A. Spanevello (Tradate, Italy)
Cross-sectional validation of the German version of the Asthma Impairment and Risk Questionnaire (AIRQ) F. Kanniess (Reinfeld (Holstein), Germany), M. Lommatzsch (Rostock, Germany), T. Schultz (Berlin, Germany), H. Timmermann (Hamburg, Germany), O. Schmidt (Koblenz, Germany), S. Heindl (Gauting, Germany), K. Defosse (Hamburg, Germany), H. Baumann (Bremen, Germany), C. Lange (Düsseldorf, Germany), D. Dirlam (Berlin, Germany), C. Fernandez-Lazaro (Berlin, Germany), A. Rudolph (Berlin, Germany), S. Korn (Mainz, Germany)
Predicting asthma attack risk in real life severe asthma patients on mepolizumab G. Tavernier (Manchester (Greater Manchester), United Kingdom), L. Whipday (Manchester (Greater Manchester), United Kingdom), T. Qureshi (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom)
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR) L. Loewenthal (London, United Kingdom), J. Busby (Belfast, United Kingdom), R. Mcdowell (Belfast, United Kingdom), T. Brown (Portsmounth, United Kingdom), H. Burhan (Liverpool, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom), P. Dennison (Southampton, United Kingdom), J. Dodd (Bristol, United Kingdom), S. Doe (Newcastle Upon Tyne, United Kingdom), S. Faruqi (Hull, United Kingdom), R. Gore (Cambridge, United Kingdom), E. Idris (Stoke, United Kingdom), D. Jackson (London, United Kingdom), M. Patel (Plymouth , United Kingdom), T. Pantin ( Manchester, United Kingdom), I. Pavord (Oxford, United Kingdom), P. Pfeffer (London, United Kingdom), D. Price (Singapore, Singapore), S. Siddiqui (London, United Kingdom), L. Heaney (Belfast, United Kingdom), A. Menzies-Gow (London, United Kingdom)
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis A. Robijn (New Lambton Heights (NSW), Australia), M. Bokern (Groningen, Netherlands), M. Jensen (New Lambton Heights (NSW), Australia), D. Barker (New Lambton Heights (NSW), Australia), K. Baines (New Lambton Heights (NSW), Australia), V. Murphy (New Lambton Heights (NSW), Australia)
Severe asthma outcomes in patients self-administering biological therapy at home L. Holmes (Manchester (Greater Manchester), United Kingdom), L. Elsey (Manchester (Greater Manchester), United Kingdom), A. Simpson (Manchester (Greater Manchester), United Kingdom), G. Tavernier (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom)
T2 and T3 cytokine expression in asthma with chronic rhinosinusitis V. Carriero (Orbassano, Italy), E. Arrigo (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
Effects of menopause and fat mass in asthmatic inflammation in female asthmatics A. Papaioannou (Vrilissia (Athens), Greece), A. Papaporfyriou (Vrilissia (Athens), Greece), M. Kallieri (Vrilissia (Athens), Greece), E. Papachatzopoulou (Athens, Greece), P. Giouleka (Athens, Greece), G. Papadaki (Athens, Greece), A. Spathis (Athens, Greece), P. Bakakos (Athens, Greece), S. Papiris (Athens, Greece), S. Loukides (Athens, Greece)
Clinical, functional, and biological characterization of neutrophilic asthma phenotype and endotypes. E. Arrigo (Torino, Italy), C. Demasi (Torino, Italy), V. Carriero (Torino, Italy), F. Bertolini (Torino, Italy), G. Villetti (Parma, Italy), D. Miglietta (Parma, Italy), F. Ricciardolo (Torino, Italy)